Charles River Laboratories International (CRL) Income from Non-Controlling Interests (2009 - 2025)
Charles River Laboratories International (CRL) posted quarterly Income from Non-Controlling Interests of $265000.0 for Q4 2025, down 64.57% year-over-year from $748000.0 in Q4 2024, and down 76.63% quarter-over-quarter from $1.1 million in Q3 2025.
Charles River Laboratories International (CRL) Income from Non-Controlling Interests (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Income from Non-Controlling Interests history runs 17 years deep, the most recent figure standing at $265000.0 for Q4 2025.
- In Q4 2025, Income from Non-Controlling Interests fell 64.57% year-over-year to $265000.0; the TTM figure through Dec 2025 stood at $2.2 million (down 29.57% YoY), while the FY2025 annual figure was $2.2 million, down 29.57% from the prior year.
- Income from Non-Controlling Interests for Q4 2025 stood at $265000.0, down from $1.1 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $2.4 million in Q3 2023, with the low at $180000.0 in Q2 2024.
- The 5-year median for Income from Non-Controlling Interests is $1.2 million (2022), against an average of $1.3 million.
- The sharpest annual moves came in 2021 and 2024: Income from Non-Controlling Interests soared 3436.76% in 2021, then slumped 92.57% in 2024.
- Charles River Laboratories International's Income from Non-Controlling Interests stood at $2.2 million in 2021, then decreased by 24.59% to $1.7 million in 2022, then rose by 10.14% to $1.9 million in 2023, then plunged by 59.96% to $748000.0 in 2024, then sank by 64.57% to $265000.0 in 2025.
- Business Quant data shows CRL's Income from Non-Controlling Interests at $265000.0 in Q4 2025, $1.1 million in Q3 2025, and $367000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 14.00 Mn |
| 10 | Charles River Laboratories International | 12.89 Bn | 12.68 Bn | 1.81 Bn | 265,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 265,000.00 |
| Sep 27, 2025 | 1.13 Mn |
| Jun 28, 2025 | 367,000.00 |
| Mar 29, 2025 | 409,000.00 |
| Dec 28, 2024 | 748,000.00 |
| Sep 28, 2024 | 638,000.00 |
| Jun 29, 2024 | 180,000.00 |
| Mar 30, 2024 | 1.52 Mn |
| Dec 30, 2023 | 1.87 Mn |
| Sep 30, 2023 | 632,000.00 |
| Jul 1, 2023 | 2.42 Mn |
| Apr 1, 2023 | 823,000.00 |
| Dec 31, 2022 | 1.70 Mn |
| Sep 24, 2022 | 1.14 Mn |
| Jun 25, 2022 | 1.34 Mn |
| Mar 26, 2022 | 2.20 Mn |
| Dec 25, 2021 | 2.25 Mn |
| Sep 25, 2021 | 1.73 Mn |
| Jun 26, 2021 | 1.47 Mn |
| Mar 27, 2021 | 2.41 Mn |